ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Advocacy: Groups Urge studies Of Environmental Pollutants As Cause Of Cancer

November 5, 1999

Trials Approved by NCI CTEP For the Month of March

March 30, 2012

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

DCCP Board Approves Concepts Of $2.6 Million In New Competing Projects, $1.2 Million In Recompetitions

September 25, 1981

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002

President’s Cancer Panel annual report finds barriers in translational research stall progress.

July 8, 2005